Clinical trial
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
NCT00203996 · University of Chicago, Other · Terminated
Key facts
| NCT number | NCT00203996 |
|---|---|
| Title | Polycystic Ovary Syndrome (PCOS) and Sleep Apnea |
| Official title | Sleep, Metabolic, and Cardiovascular Dysfunction in Polycystic Ovary Syndrome |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Heart, Lung, and Blood Institute (NHLBI) |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Polycystic Ovary Syndrome, Obstructive Sleep Apnea |
| Intervention type | Device, Drug, Procedure |
| Interventions | continuous positive airway pressure (CPAP), depot leuprolide plus estrogen/progestin replacement, pioglitazone, REM frag, SWS supp |
| Enrollment | 37 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 21, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: